| Prev Close: | 2,134.00 |
|---|---|
| Open: | 2,139.00 |
| Bid: | 2,167.00 |
| Ask: | 2,169.00 |
| 1y Target Est: | 35.74 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 2,132.00 - 2,174.00 |
|---|---|
| 52wk Range: | 1,682.00 - 2,174.00 |
| Volume: | 1,907,272 |
| Avg Vol (3m): | 1,862,850 |
| Market Cap: | 11.96B |
| P/E (ttm): | 2,125.49 |
| EPS (ttm): | 1.02 |
| Div & Yield: | N/A (N/A) |
Headlines
- UK Stocks-Factors to watch on May 21at Reuters(Tue May 21)
- Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic DiseasesPR Newswire(Mon May 20)
- Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual MeetingPR Newswire(Fri May 17)
- 3 FTSE 100 Shares the Market Loves: Rio Tinto, Shire, and Experianat Motley Fool(Wed May 15)
- U.K. Stocks Extend Five-Year High as BT Climbs on Profitat Bloomberg(Fri May 10)
- Shire Wins Block of Actavis’s Lialda Copy Until 2020at Bloomberg(Thu May 9)
- Shire Wins Patent Trial Against Watson Concerning LIALDA®PR Newswire(Thu May 9)
- BRIEF-Shire wins patent trial against Watsonat Reuters(Thu May 9)
- Shire slumps after lowering revenue outlookAP(Thu May 2)
- ADR REPORT-ECB rate cut, jobless claims data lift ADRsat Reuters(Thu May 2)
- U.K. stocks end higher after ECB rate cutat MarketWatch(Thu May 2)
- UPDATE 1-Shire cuts sales forecast as some drugs miss Q1 targetsat Reuters(Thu May 2)
- BRIEF-Shire's Ornskov says will refocus on late-stage pipelineat Reuters(Thu May 2)
- Shire Cuts Full-Year Sales Forecast as Revenue Misses Estimatesat Bloomberg(Thu May 2)
- Shire delivers Q1 earnings beat on strong product salesat Reuters(Thu May 2)
Press Releases
- Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic DiseasesPR Newswire(Mon May 20)
- Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual MeetingPR Newswire(Fri May 17)
- Shire Wins Patent Trial Against Watson Concerning LIALDA®PR Newswire(Thu May 9)
Must Read
- Weather still not co-operating as Jersey shore seeks to jump-start 1st summer after SandyThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Closed business in Corner Brook an eyesore, says board of tradeCBC(1969-12-31T18:59:59GMT-05:00)
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(1969-12-31T18:59:59GMT-05:00)